SB
SBIO.AS Invesco NASDAQ Biotech UCITS ETF
68.11 EUR
Close of Oct 29, 2026
47.01
68.11
- Total assets
- 276M
- Expense ratio
- 0.41%
- Dividend yield
- 0.85%
- 1-year return
- +36.39%
- Holdings
- 1
- Since
- 2014
Fund data as reported by the issuer, updated Oct 28, 2026. Total assets are in the fund's base currency.
What does SBIO.AS invest in?
Tracks Morningstar Gbl Biotechnology NR USD- Mostly US stocks (97.4%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (91.9%)
Asset allocation
- US stocks 97.4%
- Non-US stocks 4.7%
Invesco NASDAQ Biotech UCITS ETF performance
Sharpe ratio 1.03- This year
- +23.85%
- 1 year
- +36.39%
- 3 years
- +25.23%
- 5 years
- +8.17%
Volatility 17.1% over 1 year and 17.6% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
SBIO.AS price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Invesco NASDAQ Biotech UCITS ETF top holdings
The holdings of Invesco NASDAQ Biotech UCITS ETF are not available yet.
SBIO.AS sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
SBIO.AS regional exposure
- North America91.9%
- Europe Developed2.2%
- United Kingdom1.9%
- Asia Emerging0.1%
- Australasia0.0%
- Africa/Middle East0.0%
- Asia Developed0.0%
Share of the stocks in the fund.
Company size
Average market cap 24.9B- Mega cap0.6%
- Big cap25.8%
- Medium cap34.6%
- Small cap25.5%
- Micro cap11.6%
Invesco NASDAQ Biotech UCITS ETF fund profile
- Fund name
- Invesco NASDAQ Biotech UCITS ETF
- Ticker
- SBIO.AS
- Exchange
- Euronext Amsterdam
- Index tracked
- Morningstar Gbl Biotechnology NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Nov 6, 2014
- Trading currency
- EUR
- Expense ratio
- 0.41%